Patents by Inventor Hye-Youn Sung

Hye-Youn Sung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR DIAGNOSING OVARIAN CANCER METASTASIS BY USING CPG METHYLATION IN GENE, AND USE THEREOF
    Publication number: 20160265061
    Abstract: The present invention relates to a composition, a kit and a method for diagnosing ovarian cancer metastasis or predicting risk of the metastasis by detecting methylation levels at CpG sites of one or more genes selected from the group consisting of ADAM12 (a disintegrin and metalloproteinase 12), NTN4 (netrin 4), and PTGS2 (prostaglandin-endoperoxide synthase 2).
    Type: Application
    Filed: September 4, 2014
    Publication date: September 15, 2016
    Applicant: EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
    Inventors: Jung-Hyuck AHN, Woong JU, Hye-Youn SUNG
  • Composition for diagnosing Alzheimer's disease using methylation status of HMOX1 gene and method for diagnosing Alzheimer's disease using the same
    Patent number: 9133521
    Abstract: The present invention relates to a diagnostic composition for Alzheimer's disease which includes an agent measuring the methylation level of HMOX1 gene promoter, a diagnostic kit and a method for diagnosing Alzheimer's disease using the same.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: September 15, 2015
    Assignee: EWHA UNIVERSITY—INDUSTRY COLLABORATION FOUNDATION
    Inventors: Jung-Hyuck Ahn, Hye-Youn Sung
  • COMPOSITION FOR DIAGNOSING OVARIAN CANCER METASTASIS USING CPG METHYLATION STATUS OF GENE PROMOTER AND USE THEREOF
    Publication number: 20140243218
    Abstract: The present invention relates to a composition, a kit and a method for diagnosing ovarian cancer metastasis or predicting the risk of metastasis by detecting methylation levels at CpG sites of one or more gene promoters selected from the group consisting of AGR2 (anterior gradient 2), CA9 (carbonic adj anhydrase 9), GABRP (gamma-aminobutyric acid receptor pi subunit), IFITM1 (interferon-induced transmembrane 1) and MUC13 (mucin 13).
    Type: Application
    Filed: February 20, 2014
    Publication date: August 28, 2014
    Applicant: Ewha University - Industry Collaboration Foundation
    Inventors: Jung-Hyuck AHN, Hye-Youn Sung, Woong Ju
  • Composition for diagnosing Alzheimer's disease using methylation status of HMOX1 gene and method for diagnosing Alzheimer's disease using the same
    Publication number: 20140162252
    Abstract: The present invention relates to a diagnostic composition for Alzheimer's disease which includes an agent measuring the methylation level of HMOX1 gene promoter, a diagnostic kit and a method for diagnosing Alzheimer's disease using the same.
    Type: Application
    Filed: April 25, 2013
    Publication date: June 12, 2014
    Inventors: Jung-Hyuck AHN, Hye-Youn Sung